BEEJAL VADHAR: Open Payments
NPI 1740972827 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$998 in 58 payments from 18 companies in 2025. Trend: 2023 $131 · 2024 $508 · 2025 $998
Food & beverage: $998
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $179 |
| QOL Medical, LLC | 4 | $113 |
| Ipsen Biopharmaceuticals, Inc | 4 | $94 |
| Ardelyx, Inc. | 5 | $79 |
| Madrigal Pharmaceuticals | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $64 |
| Phathom Pharmaceuticals, Inc. | 6 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| GENZYME CORPORATION | 2 | $50 |
| Lilly USA, LLC | 2 | $43 |
Products named: DUPIXENT, Sucraid, RINVOQ, IQIRVO, IBSRELA, REZDIFFRA, VOQUEZNA, ENTYVIO.
Industry payments across SC — which companies pay providers there.
